January 14-16, 2025
|
Overview:
JP Morgan Healthcare Conference 2025 Join director Thom Busby, senior vice president Nick Frame, and managing director Paul Mieyal at the JP Morgan Healthcare Conference 2025. |
The New Orleans biotech is currently raising a tiny $8 million Series A to develop its non-opioid painkiller. It keeps costs low by paying employees cash on an hourly basis—but no salaries.
Read MoreOutcome Capital Life Science Market Pulse March 2025 Click to view our LifeSciences Pulse Newsletter
DownloadWould you like to learn more about working with Outcome Capital or discuss your specific needs?